These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9137327)

  • 1. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia.
    Valter I; Maricq HR
    Scand J Rheumatol; 1997; 26(2):117-24. PubMed ID: 9137327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Raynaud's phenomenon in 2 ethnic groups in the general population of Estonia.
    Valter I; Maricq HR
    J Rheumatol; 1998 Apr; 25(4):697-702. PubMed ID: 9558171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for coronary heart disease in 55- and 35-year-old men and women in Sweden and Estonia.
    Johansson J; Viigimaa M; Jensen-Urstad M; Krakau I; Hansson LO
    J Intern Med; 2002 Dec; 252(6):551-60. PubMed ID: 12472917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of scleroderma spectrum disorders in the general population of Estonia.
    Valter I; Saretok S; Maricq HR
    Scand J Rheumatol; 1997; 26(6):419-25. PubMed ID: 9433401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon: prevalence in an Italian population sample.
    De Angelis R; Salaffi F; Grassi W
    Clin Rheumatol; 2006 Jul; 25(4):506-10. PubMed ID: 16292469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.
    Maricq HR; Carpentier PH; Weinrich MC; Keil JE; Palesch Y; Biro C; Vionnet-Fuasset M; Jiguet M; Valter I
    J Rheumatol; 1997 May; 24(5):879-89. PubMed ID: 9150076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, risk factors, and clinical correlates of ulnar artery occlusion in the general population.
    Carpentier PH; Biro C; Jiguet M; Maricq HR
    J Vasc Surg; 2009 Dec; 50(6):1333-9. PubMed ID: 19837535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France.
    Maricq HR; Carpentier PH; Weinrich MC; Keil JE; Franco A; Drouet P; Ponçot OC; Maines MV
    J Rheumatol; 1993 Jan; 20(1):70-6. PubMed ID: 8441170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
    Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
    Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Raynaud's phenomenon assisted by color charts.
    Maricq HR; Weinrich MC
    J Rheumatol; 1988 Mar; 15(3):454-9. PubMed ID: 3379622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus.
    Caspary L; Schmees C; Schoetensack I; Hartung K; Stannat S; Deicher H; Creutzig A; Alexander K
    J Rheumatol; 1991 Apr; 18(4):559-66. PubMed ID: 2066948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Raynaud's phenomenon in Great Britain and its relation to hand transmitted vibration: a national postal survey.
    Palmer KT; Griffin MJ; Syddall H; Pannett B; Cooper C; Coggon D
    Occup Environ Med; 2000 Jul; 57(7):448-52. PubMed ID: 10854496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population.
    O'Keeffe ST; Tsapatsaris NP; Beetham WP
    J Rheumatol; 1992 Sep; 19(9):1415-7. PubMed ID: 1433009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold climate could be an etiologic factor involved in Raynaud's phenomenon physiopathology. Epidemiological investigation from 954 consultations in general practic.
    Plissonneau Duquene P; Pistorius MA; Pottier P; Aymard B; Planchon B
    Int Angiol; 2015 Oct; 34(5):467-74. PubMed ID: 25394956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Raynaud's phenomenon in a healthy Greek population.
    Voulgari PV; Alamanos Y; Papazisi D; Christou K; Papanikolaou C; Drosos AA
    Ann Rheum Dis; 2000 Mar; 59(3):206-10. PubMed ID: 10700429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Raynaud's phenomenon in a healthy Spanish population.
    Riera G; Vilardell M; Vaqué J; Fonollosa V; Bermejo B
    J Rheumatol; 1993 Jan; 20(1):66-9. PubMed ID: 8441168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
    Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
    Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for Raynaud's phenomenon in the workforce.
    Roquelaure Y; Ha C; Le Manac'h AP; Bodin J; Bodere A; Bosseau C; Descatha A; Leclerc A; Goldberg M; Imbernon E
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):898-904. PubMed ID: 22246858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Raynaud's phenomenon in healthy Turkish medical students and hospital personnel.
    Cakir N; Pamuk ON; Dönmez S; Barutçu A; Diril H; Odabaş E; Kiliçcigil V
    Rheumatol Int; 2008 Dec; 29(2):185-8. PubMed ID: 18682952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.